Loading company…
Won 6 federal SBIR/STTR research awards from HHS and other federal agencies.
RIDGELINE THERAPEUTICS INC has been awarded 6 US Small Business Innovation Research (SBIR/STTR) contracts totalling $6,774,708 between 2018 and 2025. These are non-dilutive federal research grants, not equity financing. The company is based in HOUSTON, Texas.
No investors recorded yet for RIDGELINE THERAPEUTICS INC.
Add an investorRIDGELINE THERAPEUTICS INC has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for RIDGELINE THERAPEUTICS INC.
Add diversity data